Terbutaline Sulfate NDC 71872-7080

NDC codes

FDA NDC Directory

Product NDC (as listed)71872-7080Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71872-7080Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71872-7080-1	71872708001	1 VIAL in 1 BAG (71872-7080-1) / 1 mL in 1 VIALMarketed from Mar 6, 2018

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Terbutaline Sulfate
Generic name (nonproprietary): terbutaline sulfate
Active ingredients: Terbutaline sulfate — 1 mg/mL
Dosage form: Injection
Route: Subcutaneous
Labeler: Medical Purchasing Solutions. LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078630
Marketing start: May 20, 2009
Listing expires: Dec 31, 2026
Identifiers: Product ID 71872-7080_fc5fc617-c901-4ee6-e053-6294a90aeb43SPL ID fc5fc617-c901-4ee6-e053-6294a90aeb43SPL set ID 6a22b62c-4ee1-49df-e053-2a91aa0a3e52RxCUI 857635UNII 576PU70Y8E

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N471872708001 followed by a unit qualifier and the quantity

Package 71872-7080-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 23, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Terbutaline Sulfate Injection, USP is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 078630

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078630
Product	Strength	Form · route	Labeler	Product NDC
Terbutaline Sulfate	Terbutaline sulfate 1 mg/mL	InjectionSubcutaneous	Hikma Pharmaceuticals USA Inc.	0143-9746
Terbutaline Sulfate	Terbutaline sulfate 1 mg/mL	InjectionSubcutaneous	Hikma Pharmaceuticals USA Inc.	0143-9375